- Home
- FRVO vs BIO Comparison
FRVO vs BIO Comparison
Compare FRVO & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FRVO | BIO |
|---|---|---|
| Founded | N/A | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Laboratory Analytical Instruments |
| Sector | Utilities | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 8.0B |
| IPO Year | 2026 | 1994 |
Fundamental Metrics
Financial Performance| Metric | FRVO | BIO |
|---|---|---|
| Price | $16.31 | $388.69 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $339.75 |
| AVG Volume (30 Days) | ★ 3.5M | 275.3K |
| Earning Date | N/A | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 142.61 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,583,200,000.00 |
| Revenue This Year | N/A | $2.74 |
| Revenue Next Year | N/A | $3.20 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 0.65 |
| 52 Week Low | $15.31 | $236.73 |
| 52 Week High | $41.42 | $385.92 |
Technical Indicators
Market Signals| Indicator | FRVO | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 29.04 | 78.90 |
| Support Level | N/A | $289.16 |
| Resistance Level | $27.83 | N/A |
| Average True Range (ATR) | 2.12 | 10.41 |
| MACD | -0.34 | 1.72 |
| Stochastic Oscillator | 1.93 | 95.01 |
Price Performance
Historical ComparisonAbout BIO Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.